Genomics

Dataset Information

Phase 2 study of Nivolumab and Entinostat in unresectable or metastatic cholangiocarcinoma and pancreatic adenocarcinoma


ABSTRACT: Phase 2 study of Nivolumab and Entinostat in unresectable or metastatic cholangiocarcinoma and pancreatic adenocarcinoma

PROVIDER: PRJNA1102449 | ENA |

REPOSITORIES: ENA